IP Library Granted Patent US 8,211,005
Granted Patent B2
US 8,211,005 · App. 12/321,546 · Granted Jul 3, 2012

Method and apparatus for treating pelvic organ prolapse

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,211,005
App. No.
12/321,546
Granted
Jul 3, 2012
Kind
B2
Abstract

A method of treating pelvic organ prolapse is provided. The method generally includes the steps of establishing a first pathway between the external perirectal region of the patient to the region of the ischial spine in tissue on one side of the prolapsed organ, followed by establishing a second pathway in tissue on the contralateral side of the prolapsed organ. A support member, which includes a central support portion and two end portions, is positioned in a position to reposition said prolapsed organ in said organ's anatomically correct location. The end portions of the support member are introduced through the respective tissue pathways, followed by adjustment of the end portions so that the support member is located in a therapeutic relationship to the prolapsed organ that is to be supported. An apparatus and kit for said treatment is further provided.

Claims (78)

1. A method for repair of vaginal vault prolapse in a patient, said method comprising the steps of:

making a midline incision in an apex of a vagina;

establishing a first pathway in tissue on a first side of said prolapsed organ, by:

making a first incision lateral and posterior to the rectum in a skin of a buttocks, and

passing a needle from said first incision toward said midline incision, by:

palpating a tip of said needle distal and inferior to an ischial spine, and

passing said needle through coccygeous muscle;

establishing a second pathway in tissue on a contralateral side of said prolapsed organ, by:

making a second incision lateral and posterior to the rectum in a skin of a buttocks on the contralateral side respective to said first incision, and

passing a needle from said second incision toward said medial incision, by:

palpating a tip of said needle distal and inferior to an ischial spine, and

passing said needle through coccygeous muscle;

positioning a support member in a position to reposition said vaginal vault in said vaginal vault's anatomically correct location, said supporting member comprising a support portion having a first and second end, and two end portions, said end portions respectively attached to said first end and said second end;

introducing said end portions through said first and second pathways, respectively; and

adjusting said end portions so that said support member is in a therapeutic relationship to a tissue of said vaginal vault.

2. The method of claim 1 , wherein introducing an end portion through a pathway comprises retracting back through the pathway a needle to which said end portion has been connected.

3. The method of claim 1 , wherein adjusting said end portions so that said support member is in a therapeutic relationship to a tissue of said vaginal vault comprises:

attaching said support member to vaginal tissue with sutures;

ensuring the vaginal vault is in an appropriate anatomical position; and

adjusting said support member by manipulation of said end portions.

4. The method of claim 1 , wherein the implant includes exactly two elongated end portions.

5. A system for treating pelvic organ prolapse in a patient comprising an implant and a needle:

the implant comprising

a support portion having first and second ends;

a first elongated end portion connected to said first end of said support portion;

a second elongated end portion connected to said second end of said support portion; and

a connector at a distal end of at least one of the first elongated end portion and the second elongated end portion, and

the needle having an end that connects to the connector

wherein said support portion comprises a first and second long side and two short sides, wherein said first and second end portions are connected to said first and second long sides, respectively.

6. The system of claim 5 , further comprising a repositioning means to effect tightening or loosening said first and second elongated end portions.

7. The system of claim 6 , wherein said repositioning means comprises at least one filament threaded along at least one end portion.

8. The system of claim 6 , wherein said repositioning means comprises at least one removable sheath on at least one end portion.

9. The system of claim 5 , wherein said support portion is made from a polypropylene monofilament mesh.

10. The system of claim 5 , wherein said support portion and said end portions are substantially comprised in a single article, wherein said support portion exhibits a width, the end portions exhibit a width, and the width of the support portion is greater than the width of the end portions.

11. The system of claim 5 wherein each of the first and second end portions comprises a connector configured to attach securely with the end of the needle.

12. The system of claim 11 wherein each of the first and second end portions comprises a removable sheath, and each connector is attached to a removable sheath.

13. The system of claim 5 , wherein the implant includes exactly two elongated end portions.

14. A method for repair of pelvic organ prolapse in a patient, said method comprising the steps of:

providing an implant comprising a support portion having first and second ends, a first elongated end portion connected to said first end of said support portion, a second elongated end portion connected to said second end of said support portion, and a connector at a distal end of at least one of the first elongated end portion and the second elongated end portion,

positioning the support portion in a position to reposition said prolapsed organ in said organ's anatomically correct location;

providing a needle having an end that engages the connector,

using the needle to establish a pathway in tissue on a first side of said prolapsed organ, said pathway extending from an external perirectal region to a region of an ischial spine of the patient;

following passage of the needle through the pathway, connecting the connector with the needle end; and

retracting the needle through the pathway and external incision to place the at least one of said first elongated end portion and second elongated end portion at the pathway.

15. A method according to claim 14 , wherein the implant comprises a connector at a distal end of at each of the first elongated end portion and the second elongated end portion, the method comprising:

using a needle to establish a first pathway in tissue on a first side of said prolapsed organ, said first pathway extending from a first external perirectal region to a region of an ischial spine of the patient;

following passage of the needle through the first pathway, connecting a first connector with the needle end;

retracting the needle through the first pathway and first external incision to place the end portion at the first pathway;

using a needle to establish a second pathway in tissue on a second side of said prolapsed organ, said second pathway extending from a second external perirectal region to a region of an ischial spine of the patient;

following passage of the needle through the second pathway, connecting a second connector with the needle end; and

retracting the needle through the second pathway and second external incision to place the end portion at the second pathway.

16. The method of claim 14 , wherein said support portion is wider relative to said end portions.

17. The method of claim 14 , wherein each needle is arc-shaped.

18. The method of claim 14 , wherein the implant includes exactly two elongated end portions.

19. A system for treating pelvic organ prolapse in a patient, the system comprising an implant and a needle:

the implant comprising

a support portion having first and second ends;

a first elongated end portion connected to said first end of said support portion;

a second elongated end portion connected to said second end of said support portion; and

a connector at a distal end of at least one of the first elongated end portion and the second elongated end portion,

the needle having an end that connects to the connector,

the system comprising a repositioning means to effect tightening or loosening said first and second elongated end portions, the repositioning means comprising at least one filament threaded along at least one end portion.

20. The system of claim 19 , wherein

said repositioning means comprises at least one removable sheath on at least one end portion,

said support portion comprises a first and second long side and two short sides, wherein said first and second end portions are connected to said first and second long sides, respectively, and

each of the first and second end portions comprises a connector configured to attach securely with the end of the needle.

21. An system for treating pelvic organ prolapse in a patient comprising an implant and a needle:

the implant comprising

a support portion having first and second ends;

a first elongated end portion connected to said first end of said support portion;

a second elongated end portion connected to said second end of said support portion; and

a connector at a distal end of at least one of the first elongated end portion and the second elongated end portion, and

the needle having an end that connects to the connector,

wherein the support portion and the end portions are substantially comprised in a single article, and the support portion exhibits a width, the end portions exhibits a width, and the width of the support portion is greater than the width of the end portions.

22. The system of claim 21 , wherein

the implant comprises repositioning means comprises at least one removable sheath on at least one end portion, and

the support portion comprises a first and second long side and two short sides, and

the first and second end portions are connected to the first and second long sides, respectively.

Assignments (16)
SECURITY INTEREST Recorded Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2024
From: ASTORA WOMEN’S HEALTH, LLC
To: ENDO USA, INC.
Reel/Frame 067202/0768 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
CHANGE OF NAME Recorded Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →